05/13/2025
3:20 PM | Tvardi Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K/A | |
05/02/2025
5:12 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 4/A | |
05/02/2025
5:19 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4/A | |
05/02/2025
3:21 PM | Tvardi Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
Tweardy David John (Filed by)
| Form SCHEDULE 13G | |
04/22/2025
1:26 PM | Solas Tvardi Sidecar LLC (Filed by)
Tvardi Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form SCHEDULE 13G | |
04/21/2025
4:15 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Smith Cynthia (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Shiff Susan Ph.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TVRD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/21/2025
4:15 PM | Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:19 PM | Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:22 PM | Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:24 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:26 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:28 PM | Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:30 PM | O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:05 PM | Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:08 PM | Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:11 PM | Smith Cynthia (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:13 PM | Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:16 PM | Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2025
3:16 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:30 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
AI Meltdown Imminent: Dump These Stocks Now! (Ad) If you have any money in the markets, especially in AI stocks…
Please click here to see Elon Musk’s new invention…
This could send many popular AI stocks crashing, including Nvidia.
And it could happen starting as soon as June 1st. Click here to see the details and learn how to prepare for the next AI revolution |
03/24/2025
3:30 PM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form 425 | |
02/17/2025
11:15 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
4:13 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 424B3 | |
02/14/2025
5:01 AM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form S-4/A | |
02/06/2025
6:15 PM | Cara Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:19 AM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form S-4/A | |
01/21/2025
7:50 AM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
7:53 AM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form 425 | |
01/17/2025
3:43 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
3:44 PM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form 425 | |
12/30/2024
3:02 PM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form 425 | |
12/30/2024
3:01 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:10 PM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SCHEDULE 13D/A | |
12/18/2024
3:26 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
12/18/2024
6:23 AM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
6:25 AM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form 425 | |
11/22/2024
3:09 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:51 PM | Cara Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:21 PM | Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SC 13D | |
08/01/2024
3:15 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Cara Therapeutics, Inc. (Subject)
Cara Therapeutics (Subject)
| Form SC 13G/A | |
06/12/2024
4:12 PM | Cara Therapeutics, Inc. (Filer)
Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
3:26 PM | Cara Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:28 PM | Boudreau Helen M (Reporting)
Cara Therapeutics, Inc. (Issuer)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
